全文获取类型
收费全文 | 293篇 |
免费 | 23篇 |
专业分类
儿科学 | 7篇 |
妇产科学 | 10篇 |
基础医学 | 30篇 |
口腔科学 | 3篇 |
临床医学 | 20篇 |
内科学 | 166篇 |
皮肤病学 | 3篇 |
神经病学 | 6篇 |
特种医学 | 1篇 |
外科学 | 23篇 |
综合类 | 2篇 |
预防医学 | 27篇 |
药学 | 6篇 |
肿瘤学 | 12篇 |
出版年
2023年 | 4篇 |
2021年 | 3篇 |
2020年 | 4篇 |
2019年 | 6篇 |
2018年 | 3篇 |
2017年 | 5篇 |
2016年 | 5篇 |
2014年 | 3篇 |
2013年 | 15篇 |
2012年 | 18篇 |
2011年 | 15篇 |
2010年 | 7篇 |
2009年 | 5篇 |
2008年 | 5篇 |
2007年 | 17篇 |
2006年 | 8篇 |
2005年 | 8篇 |
2004年 | 9篇 |
2003年 | 7篇 |
2002年 | 8篇 |
2001年 | 9篇 |
2000年 | 6篇 |
1999年 | 7篇 |
1998年 | 4篇 |
1997年 | 3篇 |
1996年 | 3篇 |
1995年 | 5篇 |
1993年 | 3篇 |
1992年 | 8篇 |
1991年 | 5篇 |
1990年 | 7篇 |
1989年 | 4篇 |
1988年 | 5篇 |
1987年 | 7篇 |
1986年 | 9篇 |
1985年 | 9篇 |
1984年 | 8篇 |
1983年 | 6篇 |
1982年 | 5篇 |
1981年 | 3篇 |
1978年 | 2篇 |
1976年 | 3篇 |
1975年 | 7篇 |
1974年 | 6篇 |
1973年 | 2篇 |
1972年 | 3篇 |
1971年 | 5篇 |
1970年 | 6篇 |
1968年 | 2篇 |
1967年 | 2篇 |
排序方式: 共有316条查询结果,搜索用时 0 毫秒
1.
2.
Tacjana Pressler Gitte Kronborg Geoffry H. Shand Bendt Mansa Niels Høiby 《Medical microbiology and immunology》1992,181(6):339-349
IgG subclass antibodies to Pseudomonas aemginosa outer membrane proteins (OMP) were investigated in serum from cystic fibrosis (CF) patients by immunoblotting and enzyme-linked immunosorbent assay (ELISA). Fifteen patients (eight in good and seven in poor clinical condition) have been followed for an average of 13 years with multiple serum samples covering the preinfection, and early and late stages of chronic infection. Laser-scanning densitometry of photographs taken from immunoblots was used to quantify antibody level and compare with ELISA titres. The earliest anti-OMP antibodies to appear were of the IgG1 subclass. There was no significant difference in IgG subclass antibody levels to OMPs between patients in relatively good and poor clinical condition. Data presented indicate a high positive correlation among measurements of IgG subclass antibodies to P. aeruginosa OMPs using ELISA and immunoblotting. 相似文献
3.
Christiansen Anne Simone Juhl Mller Marie Louise Sletskov Kronborg Christian Haugan Ketil Jrgen Kber Lars Hjberg Sren Brandes Axel Graff Claus Diederichsen Sren Zga Nielsen Jonas Bille Krieger Derk Holst Anders Gaarsdal Svendsen Jesper Hastrup 《The European journal of health economics》2021,22(4):621-628
The European Journal of Health Economics - EQ-5D is a generic instrument to measure health-related quality of life. In 2009, a new version, EQ-5D-5L, was introduced as an attempt to reduce ceiling... 相似文献
4.
Screening for Early Colorectal Cancer 总被引:2,自引:0,他引:2
Kronborg O 《World journal of surgery》2000,24(9):1069-1074
There is now solid evidence from randomized trials suggesting that it is possible to reduce mortality from colorectal cancer by 15% to 25% by screening with fecal occult blood tests (FOBTs). The major benefit results from detection of early cancer in average-risk persons above 50 years of age who have a positive test followed by colonoscopy. However, it has to be demonstrated that the same acceptability can be reached in the general population as that obtained in trials. Many countries must establish a screening organization in a limited area to learn how satisfactory quality assurance can be obtained before a country-wide screening program is set up. So far, screening has not resulted in a reduced incidence of colorectal cancer in true population studies despite removal of two to three times as many possible precursors compared to controls. Cost-effectiveness will probably be as good as that known from screening for breast cancer with mammography and better than that for cervical cancer. However, the calculations are based on the unhydrated Hemoccult-II test in randomized trials. More sensitive methods would be attractive, but none has yet been evaluated properly in average-risk persons. There is no general agreement how to screen high risk groups such as patients with previous colorectal adenomas and carcinomas, one or two first-degree relatives with colorectal neoplasia, or ulcerative colitis. Families with familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer, however, are presented with firm guidelines. Genetic screening has been helpful in no more than these two small groups in the colorectal carcinoma universe. 相似文献
5.
6.
Fyenbo Daniel Benjamin Sommer Anders Stephansen Charlotte Nørgaard Bjarne Linde Kronborg Mads Brix Kristensen Jens Gerdes Christian Jensen Henrik Kjærulf Jensen Jesper Møller Nielsen Jens Cosedis 《Journal of interventional cardiac electrophysiology》2022,64(3):783-792
Journal of Interventional Cardiac Electrophysiology - To evaluate the association between different right ventricular (RV) lead positions as assessed by cardiac computed tomography (CT) and... 相似文献
7.
8.
9.
Kronborg O 《Best Practice & Research: Clinical Gastroenterology》2001,15(2):301-316
Screening for colorectal cancer has not obtained worldwide acceptance in spite of its proven survival benefit for average-risk persons and some high-risk groups. The incidence of and mortality from colorectal cancer are worrying in Europe as well as in the USA, Australia and Japan. The best evidence-based studies are those published on screening using faecal occult blood tests, endoscopic methods and different tumour markers having been evaluated to a lesser degree. Feasibility studies are necessary before massive screening can be undertaken because the results obtained from randomized studies may not be reproduced to a satisfactory degree in average- as well as high-risk populations. Primary prevention by dietary intervention and drugs has been studied in great detail, so far without any major breakthrough. This chapter will address different screening methods in populations with a varying risk of colorectal cancer, together with providing a short review of prevention and intervention strategies. 相似文献
10.
Lohse N Hansen AB Jensen-Fangel S Kronborg G Kvinesdal B Pedersen C Larsen CS Møller A Willumsen L Obel N 《Scandinavian journal of infectious diseases》2005,37(5):338-343
We used a population-based cohort study design to describe the demographic characteristics of the HIV-infected population in Denmark and their variation over time. HIV treatment in Denmark is restricted to 9 centres, and all 3941 HIV-1 infected patients more than 15 y old seen at these centres in 1995-2003 were included. We found an estimated HIV prevalence of 70 per 100,000, and a mean annual incidence rate of 5.1 per 100,000 persons. The number of newly infected individuals was stable with a median of 231 per y (period 1995-2002), whereas the number of deaths decreased from 166 in 1995 to 50 in 2000 (p=0.000) and remained stable thereafter. Of the enrolled patients, 75% were males, 80% were Caucasian, 13% were black African, and the primary risk behaviour was male-to-male sexual contact (44%), heterosexual contact (36%), and injection drug use (11%). During the y 1995-2003 we found an increase in age at diagnosis (p=0.000), and no major changes in gender, race, mode of infection, or baseline CD4+ cell count and viral load, neither overall not within subgroups of patients. In this period 14.5% had AIDS at the time of HIV diagnosis. Our data do not confirm concerns about unmonitored evolution in the HIV epidemic in Denmark. 相似文献